0
The German government expects vaccinations with the Novavax Covid-19 vaccine Nuvaxovid to begin across the country over the course of this week, a health ministry spokesperson said.
“We assume that over the coming week ... vaccinations can begin in the federal states,” the spokesperson told a regular government news conference.
Novavax's recombinant protein vaccine uses a more established technology than mRNA, the novel method behind the two most commonly used Covid-19 vaccines in Germany — from Pfizer/BioNTech and Moderna, Reuters reports.
